Skip to content
Screener

BioMarin Pharmaceuticals BMRN Total Liabilities

Total Liabilities at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$1.66B-28.5%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$3.05B+7.3%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$14.57M-89.5%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$82.4M-19.0%
Regenxbio logo
RegenxbioRGNX
$314.85M-14.3%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$3.64B+44.4%

Other financials

Income statement

See full
Revenue$989.7M+19.9%
Gross profit$786.9M+16.5%
Operating income$110.9M-59.9%
Net income$44.8M-81.4%
EPS (diluted)$0.23-81.3%

Balance sheet

See full
Cash & equivalents$874.0M-28.0%
Total debt$4.2B+598%
Total equity$6.3B+4.9%
Total assets$11.7B+57.2%

Cash flow

See full
Operating cash flow$168.1M-9.3%
CapEx$28.8M+68.5%
Free cash flow$139.3M-17.2%

Valuation

See full
Market cap$11.58B-0.6%
Enterprise value$14.89B+34.9%
P/E32.2×-34.7×
P/S3.4×-0.4×

Profitability

See full
Gross margin76.1%-3.4pp
Operating margin19.9%+7.2pp
Net margin16.8%+5.1pp
FCF margin21.7%-1.0pp

Returns & leverage

See full
Return on equity9.1%+2.8pp
Debt / equity0.7×+0.6×
Current ratio2.4×-3.2×

Where this comes from

Reported directly by BioMarin Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001048477-26-000016

FAQ

What is BioMarin Pharmaceuticals's total liabilities?
BioMarin Pharmaceuticals (BMRN) reported total liabilities of $5.4B in Q2 2026.
How has BioMarin Pharmaceuticals's total liabilities changed year-over-year?
BioMarin Pharmaceuticals's total liabilities increased by 277.9% year-over-year, from $1.43B to $5.4B.
What is the long-term trend for BioMarin Pharmaceuticals's total liabilities?
Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's total liabilities has grown at a -2.9% compound annual growth rate (CAGR), from $1.74B to $1.51B.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Ask your AI about BioMarin Pharmaceuticals's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude